Explore our collection of audio presentations, interviews, and telephone discussions to hear more about Alzheimer’s, macular degeneration, and glaucoma.
Let us come to you
Milam A. Brantley, Jr., MD, PhD, of the Vanderbilt Eye Institute, discusses the type of doctor that is most appropriate for monitoring and treating the wet and dry forms of age-related macular degeneration.
Orli Weisser-Pike, a doctor of occupational therapy and a certified low vision therapist is the guest speaker. She has over eighteen years of clinical experience in a wide variety of settings and has for the past decade specialized in helping people affected by low vision.
The guest speaker is Michael Allingham, MD, PhD, who is an ophthalmologist at Duke University.
Adam S. Wenick, M.D., Ph.D., who is an assistant professor of ophthalmology in the retina division at Johns Hopkins Wilmer Eye Institute is the guest speaker.
The phone conference features Brian S. McKay, PhD, who conducts basic research towards developing new cell-based therapies for macular degeneration. He discusses a major new breakthrough showing that L-DOPA, a drug widely used to treat Parkinson’s disease, may help protect against age-related macular degeneration (AMD); Maria B. Grant, MD, who conducts research using adult stem cells to repair damaged blood vessel networks within the retina that are associated with macular degeneration; and David Pepperberg, PhD, who researches methods to restore vision lost in diseases such as age-related macular degeneration.
The featured speakers for this telephone discussion are Katherine Freund, the President and Founder of the Independent Transportation Network (ITN America), a national nonprofit providing transportation to seniors and to adults with visual impairments, and Karen A. Keninger, director of the National Library Service (NLS) for the Blind and Physically Handicapped, where her top initiatives are to increase braille literacy and leveraging technology to improve service to NLS’s 500,000-plus patrons.
This telephone discussion features Christopher Brady, MD, an ophthalmologist from the Wilmer Eye Institute at Johns Hopkins University School of Medicine, who specializes in the medical and surgical management of retinal diseases, including macular degeneration. His research focuses on the benefits of telemedicine for underserved populations and how new technologies can improve patient care.